Following the FDA ODAC's vote against belantamab mafodotin-based combinations in relapsed/refractory multiple myeloma, George Mulligan, PhD, provides insight into the agent's potential path foward.

There's an unmet need for effective treatments in PTSD, as current options include psychotherapy and the SSRIs sertraline and paroxetine (Paxil). These options carry various adverse effects, and the ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

Which drug combinations are best for prevention of nausea and vomiting caused by chemotherapy in adults with cancer?

MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...

Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report second-quarter 2025 results on July 17. The Zacks Consensus Estimate for revenues is pegged at $14.04 billion, while the same for earnings ...

Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

Their findings suggest that this drug combination offers a novel strategy to help these patients control the disease in order to be eligible for stem cell transplants.

Antibody–drug conjugates (ADCs) are advanced cancer therapeutics that combine an antibody-based delivery system with a cytotoxic payload through chemical linkers. Anthraquinone-fused enediyne (AFE) ...

Our conclusions The results of our analysis suggest that there is no superior drug combination for prevention of CINV for people receiving HEC or MEC. However, results suggest that the choice of drugs ...